Search research articles
Contact Us
Filters
Showing results (161-170 of 481) with videos related to
Page
of 49
Sort By:
The New England Journal of Medicine
|
August 24, 2012
Ethical considerations in studying drug safety--the Institute of Medicine report
Michelle M Mello, Steven N Goodman, Ruth R Faden
Cadernos De Saude Publica
|
August 22, 2001
[AIDS, activism, and the regulation of clinical trials in Brazil: Protocol 028]
M A Oliveira, E M Santos, J M Mello
Health Economics
|
May 15, 2002
Do Medicare HMOs still reduce health services use after controlling for selection bias?
Michelle M Mello, Sally C Stearns, Edward C Norton
ACS Biomaterials Science & Engineering
|
January 14, 2021
Bactericidal Hydrogels via Surface Functionalization with Cecropin A
Megan A Cole, Timothy F Scott, Charlene M Mello
Plos Medicine
|
April 13, 2011
Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints
Aaron S Kesselheim, Michelle M Mello, David M Studdert
Health Affairs (Project Hope)
|
April 4, 2003
The Leapfrog standards: ready to jump from marketplace to courtroom?
Michelle M Mello, David M Studdert, Troyen A Brennan
JAMA
|
February 18, 2003
Medical monitoring for pharmaceutical injuries: tort law for the public's health?
David M Studdert, Michelle M Mello, Troyen A Brennan
Health Affairs (Project Hope)
|
December 3, 2003
The McLawsuit: the fast-food industry and legal accountability for obesity
Michelle M Mello, Eric B Rimm, David M Studdert
Accountability in Research
|
April 26, 2006
Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors
Michelle M Mello, Brian R Clarridge, David M Studdert
Joint Commission Journal on Quality and Patient Safety
|
November 1, 2005
Advising patients about patient safety: current initiatives risk shifting responsibility
Vikki A Entwistle, Michelle M Mello, Troyen A Brennan
Page
of 49
Search research articles
Search
Showing results (161-170 of 481) with videos related to
Sort By:
Page
of 49
The New England Journal of Medicine
|
August 24, 2012
Ethical considerations in studying drug safety--the Institute of Medicine report
Michelle M Mello, Steven N Goodman, Ruth R Faden
Cadernos De Saude Publica
|
August 22, 2001
[AIDS, activism, and the regulation of clinical trials in Brazil: Protocol 028]
M A Oliveira, E M Santos, J M Mello
Health Economics
|
May 15, 2002
Do Medicare HMOs still reduce health services use after controlling for selection bias?
Michelle M Mello, Sally C Stearns, Edward C Norton
ACS Biomaterials Science & Engineering
|
January 14, 2021
Bactericidal Hydrogels via Surface Functionalization with Cecropin A
Megan A Cole, Timothy F Scott, Charlene M Mello
Plos Medicine
|
April 13, 2011
Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints
Aaron S Kesselheim, Michelle M Mello, David M Studdert
Health Affairs (Project Hope)
|
April 4, 2003
The Leapfrog standards: ready to jump from marketplace to courtroom?
Michelle M Mello, David M Studdert, Troyen A Brennan
JAMA
|
February 18, 2003
Medical monitoring for pharmaceutical injuries: tort law for the public's health?
David M Studdert, Michelle M Mello, Troyen A Brennan
Health Affairs (Project Hope)
|
December 3, 2003
The McLawsuit: the fast-food industry and legal accountability for obesity
Michelle M Mello, Eric B Rimm, David M Studdert
Accountability in Research
|
April 26, 2006
Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors
Michelle M Mello, Brian R Clarridge, David M Studdert
Joint Commission Journal on Quality and Patient Safety
|
November 1, 2005
Advising patients about patient safety: current initiatives risk shifting responsibility
Vikki A Entwistle, Michelle M Mello, Troyen A Brennan
Page
of 49